Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Testicular Neoplasms × trastuzumab deruxtecan × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Neoplasm Metastasis 8 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Meningeal Carcinomatosis 1 HER2-mutant Non-Small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Ifosfamide 8 Carboplatin 7 Paclitaxel 5 Filgrastim 5 Etoposide 5 Dexamethasone 3 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Ondansetron 2 Mesna 2 Granulocyte Colony-Stimulating Factor 2 Calcium Dobesilate 2 Aprepitant 2 tremelimumab 1 thymoglobulin 1 poly ICLC 1 pembrolizumab 1 palifosfamide lysine 1 palbociclib 1 isophosphamide mustard 1 fosaprepitant 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 dehydroftorafur 1 cytokine inducible SH2-containing protein 1 alvocidib 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡